https://www.selleckchem.com/pr....oducts/elafibranor.h
The U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) is a library of items for assessing symptomatic adverse events by patient self-report in oncology trials. The aim of this multi-site study was to generate and linguistically validate a Dutch language version of the U.S. PRO-CTCAE for use in the Netherlands and Dutch-speaking Belgium. All 124 items in the PRO-CTCAE item library were translated into Dutch using established translation procedures, in
Like
Comment
Share
